Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)
about
High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin IIAnti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipidsRole of beta 2-glycoprotein I and anti-phospholipid antibodies in activation of protein C in vitroInteractions and molecular structure of cardiolipin and beta 2-glycoprotein 1 (beta 2-GP1)Gene-expression patterns predict phenotypes of immune-mediated thrombosisThe critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipinAssociation between anti-nucleophosmin and anti-cardiolipin antibodies in (NZW x BXSB)F1 mice and human systemic lupus erythematosusOxidized phospholipids and lipoprotein-associated phospholipase A2 as important determinants of Lp(a) functionality and pathophysiological roleAltered Traffic of Cardiolipin during Apoptosis: Exposure on the Cell Surface as a Trigger for "Antiphospholipid Antibodies"Thrombophilia and Recurrent Pregnancy Loss: Is heparin still the drug of choice?Immune Components of Liver Damage Associated with Connective Tissue DiseasesA Novel Dimeric Inhibitor Targeting Beta2GPI in Beta2GPI/Antibody Complexes Implicated in Antiphospholipid SyndromeThe Role of TLR4 on B Cell Activation and Anti-β2GPI Antibody Production in the Antiphospholipid SyndromeHLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosusT cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individualsAnticardiolipin antibodies in Jamaican primiparaeEffect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesiclesDomain V of beta2-glycoprotein I binds factor XI/XIa and is cleaved at Lys317-Thr318Antiphospholipid antibodies associated with alcoholic liver disease specifically recognise oxidised phospholipidsPhospholipid binding specificities and idiotype expression of hybridoma derived monoclonal autoantibodies from splenic cells of patients with systemic lupus erythematosus.The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins)Systematic review of case reports of antiphospholipid syndrome following infection.A novel pathway for human endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies.Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2.Both kinetic data and epitope mapping provide clues for understanding the anti-coagulant effect of five murine monoclonal antibodies to human beta2-glycoprotein I.Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides.Identification and characterization of a peptide mimetic that may detect a species of disease-associated anticardiolipin antibodies in patients with the antiphospholipid syndrome.Structure of the human beta2-glycoprotein I (apolipoprotein H) gene.Molecular cloning and mammalian expression of human beta 2-glycoprotein I cDNA.Do antibodies to beta2-glycoprotein 1 contribute to the better characterization of the antiphospholipid syndrome?A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies.Characteristics and pathogenic role of anti-beta2-glycoprotein I single-chain Fv domains: induction of experimental antiphospholipid syndrome.Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLE.Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndromeAnti-cardiolipin and anti-beta2 glycoprotein I antibodies in Indian patients with systemic lupus erythematosus: association with the presence of seizures.Anti-prothrombin antibodies: assay conditions and clinical associations in the anti-phospholipid syndrome.Hyperactivity in a mouse model of the antiphospholipid syndrome.Association of beta2-glycoprotein I IgG and IgM antibodies with thrombosis and thrombocytopenia.Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome.A new player in the antiphospholipid syndrome: the beta 2 glycoprotein I cofactor.
P2860
Q22254095-41AB5A65-EB6B-4589-A41F-46DC35518135Q24561680-8FF07F2F-0A92-4BDE-8127-F4C6A613BF95Q24563574-2B31C9B4-F900-4D0C-A85F-599A453302E9Q24672569-0E168735-26F2-4E7A-8064-A76F083F7629Q24685918-35D67E2F-8B76-4359-8899-3A3D255BFA03Q24798707-55F9DBE4-1757-4D31-B016-BA7A4D9B5320Q24813018-BCD91BFA-4F37-4293-8C2D-15311FB1B4E6Q26747100-B1332F0A-31A2-46E4-B7C2-4101306C2726Q26780481-A48A4146-A058-4EF7-B89C-01550D032E20Q26864495-73174224-B357-4CD5-B290-61EA36A9B64AQ27015533-1DDC505B-609A-4BB2-9F92-213B50AE9430Q27666379-84783E09-1D5F-43A5-8713-60D2A4B0DEDEQ28069430-DF872549-A299-4EEE-9106-EC7524329CCDQ28138464-4BAFC5D5-49A4-4F30-9AD0-C2C3A6A82D7DQ28143036-F57651E1-3BC9-4817-9DA5-AB4615CC250AQ28195098-0D167881-387A-4AEF-B1C5-39BDE32C9CCEQ28268679-0FA3ADC5-9EC9-4D59-AE7E-F0FC61A61995Q28291393-2B8F41A5-F295-49F7-A056-0C5F168D906CQ28364192-8EB6318E-27B6-45C4-899A-170D4C9A2EE4Q28367919-738C5960-89FB-443E-9A2D-E0706BE32603Q28379106-9B565937-A5D5-44AF-992D-5A864938D21EQ30243901-24B94B96-48F1-47ED-9E8D-F57B5592DCBDQ30422807-0DDCF006-31EE-421E-BCD2-BEA41C18E2A1Q30497721-4BBE32D1-E1FD-4775-A179-57862AC76B37Q30580637-09AA4903-A80B-41FF-A79F-A0BAED858561Q30676844-14FDC8E0-440D-452A-9B0F-6A4B9B6A235BQ30896030-83C896E3-1745-4DC1-B9BA-70614B1ACC21Q31920894-31C21B9D-671A-42DD-B220-2EB261FA5E3EQ33237339-99C0B4A9-FFA2-4F60-9487-C711ED23C666Q33330002-5FDC882F-400E-43D9-9CB8-FD1EBC7C9A11Q33330540-32195994-31B5-417D-8479-8E43F8AEE7C2Q33330858-A7D3F6D1-17AC-4655-967E-8DE723BEE770Q33331408-3C22FB58-2A8B-4937-B3F1-CF001B96D335Q33331690-A010D8E2-61F3-4950-8BE7-846C8CB646ACQ33336296-B3D65A62-95C4-4D92-9361-3584FC589258Q33337503-0943F7E3-0E18-446A-AF23-B7049C882EE6Q33338363-4B3C8425-DDFC-4E33-A8DE-5D86D5C7B93DQ33338788-FA3298A0-0A94-42C8-81BC-6722D8BDDCEDQ33341518-38F8A5A8-34E7-4EEB-94F8-29A0370F9D3DQ33350227-14DD43B1-01C9-4CD2-A05A-B810AF35011F
P2860
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Anti-phospholipid antibodies a ...... coprotein I (apolipoprotein H)
@ast
Anti-phospholipid antibodies a ...... coprotein I (apolipoprotein H)
@en
Anti-phospholipid antibodies a ...... coprotein I (apolipoprotein H)
@nl
type
label
Anti-phospholipid antibodies a ...... coprotein I (apolipoprotein H)
@ast
Anti-phospholipid antibodies a ...... coprotein I (apolipoprotein H)
@en
Anti-phospholipid antibodies a ...... coprotein I (apolipoprotein H)
@nl
prefLabel
Anti-phospholipid antibodies a ...... coprotein I (apolipoprotein H)
@ast
Anti-phospholipid antibodies a ...... coprotein I (apolipoprotein H)
@en
Anti-phospholipid antibodies a ...... coprotein I (apolipoprotein H)
@nl
P2860
P3181
P356
P1476
Anti-phospholipid antibodies a ...... coprotein I (apolipoprotein H)
@en
P2093
C N Chesterman
S A Krilis
P2860
P304
P3181
P356
10.1073/PNAS.87.11.4120
P407
P577
1990-06-01T00:00:00Z